|
1
|
Wang Y, Li X, Li Z, Zhang Y and Wang D:
YiQiFuMai injection for chronic heart failure: Protocol for a
systematic review and meta-analysis. Medicine (Baltimore).
97:e99572018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Taylor KS, Verbakel JY, Feakins BG, Price
CP, Perera R, Bankhead C and Plüddemann A: Diagnostic accuracy of
point-of-care natriuretic peptide testing for chronic heart failure
in ambulatory care: Systematic review and meta-analysis. BMJ.
361:k14502018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Neubauer S, Zeidler J, Schilling T, Engel
S, Linder R, Verheyen F, Haverich A and von der Schulenburg JG:
Suitability and usability of claims data for review of guidelines
for the treatment of chronic heart failure. Gesundheitswesen.
78:e135–e144. 2016.PubMed/NCBI
|
|
4
|
McCormack PL: Sacubitril/valsartan: A
review in chronic heart failure with reduced ejection fraction.
Drugs. 76:387–396. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Carvalho VO: Aerobic exercise prescription
in patients with chronic heart failure: A review in the
beta-blocker era. J Cardiovasc Med (Hagerstown). 13:570–574. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Augustin U and Henschke C: Does
telemonitoring lead to health and economic benefits in patients
with chronic heart failure? -a systematic review. Gesundheitswesen.
74:e114–121. 2012.(In German). PubMed/NCBI
|
|
7
|
Zhang X, Ma LL, Yao DK and Wang LX:
Prediction values of T wave alternans for sudden cardiac death in
patients with chronic heart failure: A brief review. Congest Heart
Fail. 17:152–156. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Antoniadis AP, Sieniewicz B, Gould J,
Porter B, Webb J, Claridge S, Behar JM and Rinaldi CA: Updates in
cardiac resynchronization therapy for chronic heart failure: Review
of multisite pacing. Curr Heart Fail Rep. 14:376–383. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Antoniadis AP, Sieniewicz B, Gould J,
Porter B, Webb J, Claridge S, Behar JM and Rinaldi CA: Erratum to:
Updates in cardiac resynchronization therapy for chronic heart
failure: Review of multisite pacing. Curr Heart Fail Rep.
14:3842017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Health Quality Ontario: Effect of early
follow-up after hospital discharge on outcomes in patients with
heart failure or chronic obstructive pulmonary disease: A
systematic review. Ont Health Technol Assess Ser. 17:1–37.
2017.
|
|
11
|
Wang W, Jiang T, Li C, Chen J, Cao K, Qi
LW, Li P, Zhu W, Zhu B and Chen Y: Will testosterone replacement
therapy become a new treatment of chronic heart failure? A review
based on 8 clinical trials. J Thorac Dis. 8:E269–E277. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vongmany J, Hickman LD, Lewis J, Newton PJ
and Phillips JL: Anxiety in chronic heart failure and the risk of
increased hospitalisations and mortality: A systematic review. Eur
J Cardiovasc Nurs. 15:478–485. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Siouta N, van Beek K, Preston N, Hasselaar
J, Hughes S, Payne S, Garralda E, Centeno C, van der Eerden M,
Groot M, et al: Towards integration of palliative care in patients
with chronic heart failure and chronic obstructive pulmonary
disease: A systematic literature review of European guidelines and
pathways. BMC Palliat Care. 15:182016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Webb N, Cowie MR, Taylor M, Briggs A,
Cohen A, de Pouvourville G, Haroun R, Trueman D and Deschaseaux C:
The cost-effectiveness of treatment for chronic heart failure: A
systematic review. Value Health. 18:A3912015. View Article : Google Scholar
|
|
15
|
Kane PM, Murtagh FE, Ryan K, Mahon NG,
McAdam B, McQuillan R, Ellis-Smith C, Tracey C, Howley C, Raleigh
C, et al: The gap between policy and practice: A systematic review
of patient-centred care interventions in chronic heart failure.
Heart Fail Rev. 20:673–687. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Macdonald PS: Combined angiotensin
receptor/neprilysin inhibitors: A review of the new paradigm in the
management of chronic heart failure. Clin Ther. 37:2199–2205. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shochat MK, Shotan A, Blondheim DS,
Kazatsker M, Dahan I, Asif A, Rozenman Y, Kleiner I, Weinstein JM,
Frimerman A, et al: Non-invasive lung IMPEDANCE-guided preemptive
treatment in chronic heart failure patients: A randomized
controlled trial (IMPEDANCE-HF Trial). J Card Fail. 22:713–722.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kervadec A, Bellamy V, El Harane N,
Arakélian L, Vanneaux V, Cacciapuoti I, Nemetalla H, Périer MC,
Toeg HD, Richart A, et al: Cardiovascular progenitor-derived
extracellular vesicles recapitulate the beneficial effects of their
parent cells in the treatment of chronic heart failure. J Heart
Lung Transplant. 35:795–807. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Markgren R, Brännström M, Lundgren C and
Boman K: Impacts of person-centred integrated chronic heart failure
and palliative home care on pharmacological heart failure
treatment: A substudy of a randomised trial. BMJ Support Palliat
Care. 9:e102016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang H, Liu Y, Lao M, Ma Z and Yi X:
Puerarin protects Alzheimer's disease neuronal cybrids from
oxidant-stress induced apoptosis by inhibiting pro-death signaling
pathways. Exp Gerontol. 46:30–37. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhu G, Wang X, Chen Y, Yang S, Cheng H,
Wang N and Li Q: Puerarin protects dopaminergic neurons against
6-hydroxydopamine neurotoxicity via inhibiting apoptosis and
upregulating glial cell line-derived neurotrophic factor in a rat
model of Parkinson's disease. Planta Med. 76:1820–1826. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Qin F, Huang X, Zhang HM and Ren P:
Pharmacokinetic comparison of puerarin after oral administration of
Jiawei-Xiaoyao-San to healthy volunteers and patients with
functional dyspepsia: Influence of disease state. J Pharm
Pharmacol. 61:125–129. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Duan S, Li YF and Luo XL: Effect of
puerarin on heart function and serum oxidized-LDL in the patients
with chronic cardiac failure. Hunan Yi Ke Da Xue Xue Bao.
25:176–178. 2000.(In Chinese). PubMed/NCBI
|
|
24
|
He H, Shi M, Yang J, Zeng X, Qiao H, Wu L
and Li L: The correlation between angiogenesis and abnormal
expression of SERCA2a, phospholamban and the endothelin pathway in
heart failure, and improvement by puerarin. Phytother Res.
22:948–956. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu B, Zhao C, Li H, Chen X, Ding Y and Xu
S: Puerarin protects against heart failure induced by pressure
overload through mitigation of ferroptosis. Biochem Biophys Res
Commun. 497:233–240. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhirov IV, Zaseeva AV, Masenko VP and
Tereshchenko SN: Peroxisome proliferator-activated receptors-alpha
(PPAR-alpha) and chronic heart failure: Is there a reason to
discuss the metabolic strategy of treatment? Ter Arkh. 86:78–82.
2014.(In Russian). PubMed/NCBI
|
|
28
|
Fu YH, Lin QX, Li XH, Fei HW, Shan ZX,
Huang XZ, Liu XY, Yang M, Lin SG, Zhou SF, et al: A novel rat model
of chronic heart failure following myocardial infarction. Methods
Find Exp Clin Pharmacol. 31:367–373. 2009.PubMed/NCBI
|
|
29
|
Zhao W, Liu L, Wang Y, Mao T and Li J:
Effects of a combination of puerarin, baicalin and berberine on the
expression of proliferator-activated receptor-γ and insulin
receptor in a rat model of nonalcoholic fatty liver disease. Exp
Ther Med. 11:183–190. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kirk RGW: Recovering the principles of
humane experimental technique: The 3Rs and the human essence of
animal research. Sci Technol Human Values. 43:622–648. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dergilev KV, Tsokolaeva ZI, Rubina KA,
Sysoeva VY, Makarevich PI, Boldyreva MA, Beloglazova IB, Zubkova
ES, Sharonov GV, Akchurin RS and Parfyonova YV: Isolation and
characterization of cardiac progenitor cells obtaining from
myocardial right atrial appendage tissue. Tsitologiia. 58:340–348.
2016.(In English, Russian). PubMed/NCBI
|
|
32
|
Sun WP, Lu YX, Zhang XY, Tang WW and Huang
QY: Effects of cocaine on activities of ATPase, LDH and SDH in
mouse splenocytes. Fa Yi Xue Za Zhi. 26:81–83. 2010.(In Chinese).
PubMed/NCBI
|
|
33
|
Lin MH, Yuan WL, Huang TC, Zhang HF, Mai
JT and Wang JF: Clinical effectiveness of telemedicine for chronic
heart failure: A systematic review and meta-analysis. J Investig
Med. 65:899–911. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yohannes AM, Chen W, Moga AM, Leroi I and
Connolly MJ: Cognitive impairment in chronic obstructive pulmonary
disease and chronic heart failure: A systematic review and
meta-analysis of observational studies. J Am Med Dir Assoc. 18:451
e451–451 e411. 2017. View Article : Google Scholar
|
|
35
|
Crowley MJ, Diamantidis CJ, McDuffie JR,
Cameron CB, Stanifer JW, Mock CK, Wang X, Tang S, Nagi A, Kosinski
AS and Williams JW Jr: Clinical outcomes of metformin use in
populations with chronic kidney disease, congestive heart failure,
or chronic liver disease: A systematic review. Ann Intern Med.
166:191–200. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Heather LC, Pates KM, Atherton HJ, Cole
MA, Ball DR, Evans RD, Glatz JF, Luiken JJ, Griffin JL and Clarke
K: Differential translocation of the fatty acid transporter,
FAT/CD36, and the glucose transporter, GLUT4, coordinates changes
in cardiac substrate metabolism during ischemia and reperfusion.
Circ Heart Fail. 6:1058–1066. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tziakas D, Chalikias G, Parissis JT,
Hatzinikolaou H, Stakos D, Papadopoulou E, Kortsaris A and Hatseras
D: Prolonged activation of tumor necrosis factor (TNF)-alpha and
its soluble receptors in chronic heart failure patients both in the
compensated and decompensated state. Interplay between their levels
and metalloproteinase-3. Eur Cytokine Netw. 15:231–239.
2004.PubMed/NCBI
|
|
38
|
Adamopoulos S, Parissis JT and Kremastinos
DT: A glossary of circulating cytokines in chronic heart failure.
Eur J Heart Fail. 3:517–526. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Afanasiev SA, Egorova MV, Kondratyeva DS,
Batalov RE and Popov SV: Comparative analysis of changes of
myocardial angiogenesis and energy metabolism in postinfarction and
diabetic damage of rat heart. J Diabetes Res. 2014:8278962014.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Amani M, Jeddi S, Ahmadiasl N, Usefzade N
and Zaman J: Effect of HEMADO on level of CK-MB and LDH enzymes
after ischemia/reperfusion injury in isolated rat heart.
Bioimpacts. 3:101–104. 2013.PubMed/NCBI
|
|
41
|
Cheng W, Wu P, Du Y, Wang Y, Zhou N, Ge Y
and Yang Z: Puerarin improves cardiac function through regulation
of energy metabolism in Streptozotocin-Nicotinamide induced
diabetic mice after myocardial infarction. Biochem Biophys Res
Commun. 463:1108–1114. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Schaun MI, Marschner RA, Peres TR,
Markoski MM and Lehnen AM: Aerobic training prior to myocardial
infarction increases cardiac GLUT4 and partially preserves heart
function in spontaneously hypertensive rats. Appl Physiol Nutr
Metab. 42:334–337. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Bodart V, Febbraio M, Demers A, McNicoll
N, Pohankova P, Perreault A, Sejlitz T, Escher E, Silverstein RL,
Lamontagne D and Ong H: CD36 mediates the cardiovascular action of
growth hormone-releasing peptides in the heart. Circ Res.
90:844–849. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Haemmerle G, Moustafa T, Woelkart G,
Büttner S, Schmidt A, van de Weijer T, Hesselink M, Jaeger D,
Kienesberger PC, Zierler K, et al: ATGL-mediated fat catabolism
regulates cardiac mitochondrial function via PPAR-α and PGC-1. Nat
Med. 17:1076–1085. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Muoio DM, MacLean PS, Lang DB, Li S,
Houmard JA, Way JM, Winegar DA, Corton JC, Dohm GL and Kraus WE:
Fatty acid homeostasis and induction of lipid regulatory genes in
skeletal muscles of peroxisome proliferator-activated receptor
(PPAR) alpha knock-out mice. Evidence for compensatory regulation
by PPAR delta. J Biol Chem. 277:26089–26097. 2002. View Article : Google Scholar : PubMed/NCBI
|
